ursodeoxycholic acid has been researched along with Alcoholic Cirrhosis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beliakin, SA; Bobrov, AN; Pliusnin, SV | 1 |
Alawad, AS; Levy, C | 1 |
Baik, SK; Cha, SH; Chang, SJ; Cho, MY; Eom, MS; Jang, YO; Jeong, PH; Kim, HS; Kim, JW; Kim, JY; Kim, MY; Kwon, SO; Suk, KT; Yea, CJ; Yoo, BS | 1 |
Causse, X; Davion, T; Labadie, H; Masliah, C; Oberti, F; Pelletier, G; Raabe, JJ; Roulot, D; Serfaty, L; Van Lemmens, C | 1 |
Buffet, C; Chaput, JC; Etienne, JP; Franco, D; Houssin, D; Labayle, D | 1 |
Parés, A; Rodés, J | 1 |
Poupon, R; Poupon, RE | 1 |
3 review(s) available for ursodeoxycholic acid and Alcoholic Cirrhosis
Article | Year |
---|---|
FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
Topics: Animals; Azepines; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Drug Evaluation, Preclinical; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Indoles; Isoxazoles; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2016 |
[Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
Topics: Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Chronic Disease; Female; Graft vs Host Disease; Hepatitis; Hepatitis, Alcoholic; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Pregnancy; Pregnancy Complications; Time Factors; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid for the treatment of cholestatic diseases.
Topics: Adult; Child; Cholangitis, Sclerosing; Cholestasis; Cystic Fibrosis; Female; Humans; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Transplantation; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 1992 |
2 trial(s) available for ursodeoxycholic acid and Alcoholic Cirrhosis
Article | Year |
---|---|
Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - a randomized open-label controlled study.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biomarkers; Biopsy; Biphenyl Compounds; Drug Therapy, Combination; Female; Gene Expression Regulation; Humans; Immunohistochemistry; Liver; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Prospective Studies; Republic of Korea; Severity of Illness Index; Tetrazoles; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice.
Topics: Adult; Aged; Bile Acids and Salts; Double-Blind Method; Female; Humans; Jaundice; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Placebos; Prognosis; Survival Analysis; Treatment Outcome; Ursodeoxycholic Acid | 2003 |
2 other study(ies) available for ursodeoxycholic acid and Alcoholic Cirrhosis
Article | Year |
---|---|
[Primary and secondary prevention of alcoholic liver cirrhosis].
Topics: Alcohol Drinking; Clinical Trials as Topic; Hepatitis B; Humans; Liver Cirrhosis, Alcoholic; Phospholipids; Practice Guidelines as Topic; Primary Prevention; Protective Agents; S-Adenosylmethionine; Secondary Prevention; Silymarin; Treatment Outcome; Ursodeoxycholic Acid | 2013 |
[Hepatology in 1981].
Topics: Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholelithiasis; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Transplantation; Peliosis Hepatis; Peritoneovenous Shunt; Ursodeoxycholic Acid | 1981 |